Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling-Reference-Cited by-同舟云学术

Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling

Published:2010-07 Issue:27 Volume:285 Page:20850-20859
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jackman Janet,Chen Yongmei,Huang Arthur,Moffat Barbara,Scheer Justin M.,Leong Steven R.,Lee Wyne P.,Zhang Juan,Sharma Navneet,Lu Yanmei,Iyer Suhasini,Shields Robert L.,Chiang Nancy,Bauer Michele C.,Wadley Diana,Roose-Girma Merone,Vandlen Richard,Yansura Daniel G.,Wu Yan,Wu Lawren C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference41 articles.

1. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

2. Immunotherapeutic perspective for bispecific antibodies

3. Highly Effective Recombinant Format of a Humanized IgG-like Bispecific Antibody for Cancer Immunotherapy with Retargeting of Lymphocytes to Tumor Cells

4. Bispecific human IgG by design

5. A revival of bispecific antibodies

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows;mAbs;2024-02-21

2. Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format;Frontiers in Immunology;2023-10-24

3. A high throughput bispecific antibody discovery pipeline;Communications Biology;2023-04-07

4. Full-length recombinant antibodies fromEscherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation;mAbs;2022-08-26

5. Advances in antibody phage display technology;DRUG DISCOV TODAY;2022